Neural Control & Coordination: Synapse Explained | NEET Biology

Postsynaptic potentials are graded potentials generated by receptor activation that determine whether a neuron fires. Excitatory postsynaptic potentials (EPSPs) occur when neurotransmitters open sodium or calcium channels, depolarizing the membrane and moving it toward the threshold for action potential firing. Inhibitory postsynaptic potentials (IPSPs) occur when neurotransmitters open potassium or chloride channels, hyperpolarizing the membrane and moving it away from threshold. Each neuron receives thousands of synaptic inputs generating both EPSPs and IPSPs that propagate as graded potentials to the trigger zone. These potentials summate spatially (multiple inputs) and temporally (multiple inputs arriving in sequence). A single EPSP rarely reaches threshold, but summation of multiple EPSPs may push the membrane potential to threshold, triggering an action potential. This integration process enables complex neural computations from simple synaptic interactions.

Synaptic integration is the process by which neurons combine multiple inputs. The postsynaptic cell sums excitatory and inhibitory postsynaptic potentials. Excitatory postsynaptic potentials (EPSPs) depolarize the postsynaptic membrane, bringing it closer to threshold. Inhibitory postsynaptic potentials (IPSPs) hyperpolarize the membrane, moving it away from threshold. If the total depolarization reaches threshold (-55 mV), an action potential is generated. Acetylcholine effects are transient because acetylcholinesterase enzyme breaks down acetylcholine in the synaptic cleft, closing receptor channels and returning the membrane to resting state.

Neurons integrate multiple excitatory (EPSPs) and inhibitory (IPSPs) postsynaptic potentials through spatial and temporal summation; EPSPs cause membrane depolarization while IPSPs cause hyperpolarization, and the balance between these opposing signals determines whether the neuron reaches the threshold to generate an action potential in the axon initial segment, where voltage-gated sodium channels are densely expressed.

Neurotransmitters produce excitatory (EPSP) or inhibitory (IPSP) postsynaptic potentials. EPSPs depolarize the membrane by opening sodium channels, while IPSPs hyperpolarize by opening chloride or potassium channels. These potentials are graded and can summate spatially (multiple inputs) or temporally (rapid successive inputs). The axon hillock integrates all inputs and generates an action potential only if the total depolarization reaches threshold.

Neurotransmitters bind to postsynaptic receptors and produce excitatory (EPSP) or inhibitory (IPSP) effects. EPSP depolarizes the neuron by opening sodium channels, moving membrane potential toward threshold (-55mV). IPSP hyperpolarizes by opening potassium or chloride channels, moving potential away from threshold. Postsynaptic receptors include ionotropic (direct ion channel opening) and metabotropic (G-protein activation) types. Synaptic potentials summate spatially (multiple synapses simultaneously) or temporally (rapid succession) to determine whether an action potential will be generated.

The neuromuscular junction is a chemical synapse where motor neurons communicate with skeletal muscle fibers through acetylcholine release; the process involves calcium-triggered exocytosis of neurotransmitter from synaptic vesicles, binding to nicotinic receptors on the postsynaptic membrane to generate end plate potentials that summate to trigger muscle contraction via excitation-contraction coupling.

Excitation-contraction coupling is the process by which electrical signals (action potentials) generated at the neuromuscular junction trigger mechanical muscle contraction. The process begins when acetylcholine released from motor neurons binds to nicotinic receptors on the muscle cell membrane, causing sodium influx and potassium efflux that generates an endplate potential. When this potential reaches threshold (-55 mV), voltage-gated sodium channels open, causing rapid depolarization to +30 mV. This depolarization spreads through T-tubules to activate dihydropyridine receptors, which mechanically trigger ryanodine receptors on the sarcoplasmic reticulum to release calcium ions. Calcium then binds to troponin, shifting tropomyosin to expose actin binding sites, enabling cross-bridge cycling and muscle contraction. Repolarization occurs as potassium channels open at +30 mV, restoring the resting membrane potential of approximately -90 mV.

This section explains the neuromuscular junction and the process of excitation-contraction coupling. The neuromuscular junction consists of a presynaptic membrane (nerve ending), a postsynaptic membrane (muscle membrane), and the synaptic cleft between them. Synaptic vesicles containing neurotransmitters are located in the presynaptic membrane. Acetylcholine is the primary neurotransmitter released at the neuromuscular junction. When an action potential reaches the presynaptic membrane, calcium ions enter, causing synaptic vesicles to release acetylcholine into the synaptic cleft. Acetylcholine binds to sodium ion voltage-gated channels on the postsynaptic membrane, causing them to open and allowing sodium ions to enter, depolarizing the membrane and generating an action potential. The action potential travels along the muscle fiber membrane and into the T-tubule system, reaching the sarcoplasmic reticulum. This triggers the release of calcium ions from the sarcoplasmic reticulum into the cytoplasm.

Muscle contraction begins at the neuromuscular junction where motor neurons synapse with muscle cells. A motor unit consists of one motor neuron and all muscle fibers it innervates. The process involves: (1) Action potential arrives at the sarcolemma, (2) Signal travels through T-tubules to the sarcoplasmic reticulum, (3) Sarcoplasmic reticulum releases calcium ions, (4) Calcium binds to troponin, (5) This displaces tropomyosin, exposing myosin binding sites on actin. Myosin cross-bridges then bind to actin and pull filaments toward the sarcomere center, shortening the muscle. ATP is required for cross-bridges to detach from actin after the power stroke.

This section provides detailed explanation of the neuromuscular junction and the process of excitation-contraction coupling. The video describes the structure of the neuromuscular junction, including the motor neuron terminal (containing vesicles filled with acetylcholine), the synaptic cleft (containing acetylcholinesterase enzyme), and the motor end plate (with acetylcholine receptors). The video explains how acetylcholine binds to nicotinic receptors, causing a conformational change that opens ion channels and allows sodium and calcium influx, depolarizing the muscle membrane. The depolarization spreads through the T-tubule system and activates voltage-gated calcium channels in the sarcoplasmic reticulum, causing calcium release. The video also covers the role of dihydropyridine receptors (DHPR) and ryanodine receptors (RyR) in calcium release, explaining that DHPR senses membrane depolarization and triggers RyR to release calcium from the sarcoplasmic reticulum.

Botox (botulinum toxin) blocks synaptic transmission by preventing vesicle fusion and neurotransmitter release. Curare mimics acetylcholine structure, binding to receptors without triggering signals. LSD mimics serotonin structure, causing hallucinations. These substances demonstrate how synaptic transmission can be pharmacologically manipulated, with implications for medicine and understanding neural function.

Drugs affect synaptic transmission through multiple mechanisms: neurotoxins like botulinum toxin (blocks vesicle fusion by destroying SNARE proteins, causing flaccid paralysis) and tetanus toxin (prevents inhibitory neurotransmitter release, causing spastic paralysis); receptor agonists like nicotine (stimulates nicotinic receptors on skeletal muscle) and muscarine (stimulates muscarinic receptors on cardiac muscle, decreasing heart rate); receptor antagonists like curare (blocks nicotinic receptors, causing paralysis) and atropine (blocks muscarinic receptors, used as antidote); and enzyme inhibitors like acetylcholinesterase inhibitors (increase neurotransmitter levels in the synaptic cleft) and reuptake inhibitors (increase neurotransmitter availability by blocking presynaptic reuptake).

Neuropharmacology manipulates synaptic events for research and therapy. To qualify as a neurotransmitter, substances must meet three criteria: synthesized and stored in presynaptic terminals, released by action potentials, and produce measurable effects on postsynaptic neurons. After signaling, neurotransmitters are removed via reuptake (pumped back into presynaptic neurons) or degradation (broken down by enzymes). Metabolites appear in bodily fluids for diagnosis. Strengthening synaptic responses involves blocking reuptake or degradation; weakening involves blocking release or receptors. Treatment challenges arise from brain compartmentalization—treating one region affects others, as seen in Parkinson's disease where global dopamine increase risks inducing schizophrenia-like symptoms.

Various substances affect synaptic transmission: caffeine, theobromine, and theophylline increase transmission by blocking adenosine receptors; strychnine blocks inhibitory glycine receptors; anesthetics and sedatives decrease transmission by enhancing inhibitory effects. Botulinum toxin blocks acetylcholine release at the neuromuscular junction, causing flaccid paralysis used therapeutically for wrinkles and overactive bladder. Tetanus toxin blocks inhibitory neurotransmitter release in the spinal cord, causing uncontrolled muscle spasms. These examples demonstrate how synaptic mechanisms can be pharmacologically modulated for therapeutic purposes.

Psychoactive substances and toxins work by blocking or enhancing neurotransmitter transmission across synapses; for example, botulism toxin prevents acetylcholine release causing paralysis, while curare blocks acetylcholine receptors, and antipsychotics like chlorpromazine reduce dopamine binding to alleviate schizophrenia symptoms.

Long-term potentiation (LTP) is the strengthening of synaptic connections between neurons, which forms the cellular basis for learning and memory. This process occurs through a coordinated mechanism involving NMDA and AMPA receptors: when glutamate binds to AMPA receptors, it depolarizes the membrane, displacing magnesium from NMDA receptors and allowing calcium influx. This calcium influx triggers intracellular signaling pathways that lead to transcription, translation, and exocytosis of additional AMPA receptors to the plasma membrane, thereby increasing synaptic sensitivity and creating lasting neural connections.

Long-term potentiation (LTP) is the cellular mechanism underlying learning and memory, where repeated firing of a presynaptic neuron leads to increased neurotransmitter release (glutamate), which binds to AMPA and NMDA receptors on the postsynaptic neuron; the increased sodium influx through AMPA receptors causes sufficient depolarization to remove magnesium block from NMDA receptors, allowing calcium entry that activates calcium-calmodulin kinase pathways, resulting in phosphorylation and insertion of more AMPA receptors, along with retrograde signaling via nitric oxide and transcription factor activation that increases synaptic connections and maintains elevated EPSP and action potential responses.

Synaptic plasticity, specifically long-term potentiation (LTP), is the biological basis of learning and memory. When we repeatedly practice a skill, the same synapse between two neurons becomes increasingly efficient at transmitting signals. This occurs because repeated activation causes more neurotransmitter receptors (particularly AMPA and NMDA receptors) to accumulate at the postsynaptic membrane, allowing more sodium and calcium ions to enter the neuron and generate stronger electrical impulses. As a result, the same stimulus produces a larger response, making neural communication more efficient over time.

Synaptic plasticity—the brain's ability to change in response to experience—is fundamental to learning and memory. Post-synaptic plasticity, involving changes in receptor composition at excitatory glutamatergic synapses, underlies long-term memory formation. Bliss and Lomo discovered Long Term Potentiation (LTP) in the hippocampus, demonstrating that high-frequency stimulation induces stable, long-lasting increases in synaptic efficacy. LTP requires depolarizing the postsynaptic cell to unblock NMDA receptors, allowing calcium influx. This activates Ca²⁺-dependent protein kinase II (CaMKII), which creates binding sites in the post-synaptic density that recruit additional mobile AMPA receptors from the plasma membrane. This receptor recruitment mechanism increases postsynaptic conductance, producing enhanced excitatory post-synaptic potentials that persist for hours to days.

Long-term potentiation (LTP) and long-term depression (LTD) represent enduring forms of synaptic plasticity essential for learning and memory. LTP occurs at glutamatergic synapses through a cascade: presynaptic glutamate release activates postsynaptic AMPA receptors, causing depolarization that removes magnesium block from NMDA receptors. Calcium influx through NMDA channels triggers protein activation that either phosphorylates existing AMPA receptors or inserts new ones into the membrane, increasing synaptic strength for hours or days. Conversely, LTD occurs at low frequencies (1 Hz) where insufficient calcium activates phosphatases instead of kinases, causing AMPA receptor dephosphorylation and removal from the membrane. These opposing mechanisms allow the nervous system to strengthen useful connections while weakening unused ones, forming the cellular basis of learning and memory storage.